secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apyx Medical Corp (APYX)
CIK:        0000719135
Form:       8-K
Filed at:   2022-06-13T23:59:59+00:00
Accession:  0000719135-22-000044
Event type: litigation
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Apyx Medical named in securities class action over off-label product statements
-------------------------------------------------------------------------------

- Plaintiff William Hattaway filed securities class action in Middle District of Florida on June 6, 2022.
- Defendants: Apyx Medical, CEO Charles Goodwin, CFO Tara Semb; claims under Sections 10(b) and 20(a).
- Allegations focus on public statements regarding off-label use of Advanced Energy products; class period May 12, 2021 - Mar 11, 2022.
- Complaint seeks unspecified damages; company states allegations are without merit and will defend vigorously.
- The complaint has not yet been served on the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/719135/000071913522000044/0000719135-22-000044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/719135/000071913522000044/apyx-20220607.htm
  HTML page:      https://secwatch.observer/filing/0000719135-22-000044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer